[PDF][PDF] Perspective on Fibroblast Activation Protein Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis-a New Paradigm for Molecular …
C Schmidkonz - Journal of Nuclear Medicine, 2021 - Soc Nuclear Med
Interstitial lung diseases (ILDs) are a heterogeneous group of parenchymal pulmonary
disorders. Their hallmark is pulmonary infiltration by immune-competent cells followed by …
disorders. Their hallmark is pulmonary infiltration by immune-competent cells followed by …
Perspective on fibroblast activation protein–specific PET/CT in fibrotic interstitial lung diseases: imaging fibrosis—a new paradigm for molecular imaging?
C Schmidkonz - Journal of Nuclear Medicine, 2022 - Soc Nuclear Med
Interstitial lung diseases (ILDs) are a heterogeneous group of parenchymal pulmonary
disorders. Their hallmark is pulmonary infiltration by immune-competent cells followed by …
disorders. Their hallmark is pulmonary infiltration by immune-competent cells followed by …
Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study
M Röhrich, D Leitz, FM Glatting, AK Wefers… - Journal of nuclear …, 2022 - Soc Nuclear Med
Interstitial lung diseases (ILDs) comprise over 200 parenchymal lung disorders. Among
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
Fibroblast activation protein-specific PET/CT imaging in idiopathic pulmonary fibrosis with lung cancer
RÃ Manuel, D Leitz, P Flechsig, N Kahn, M Mall… - 2019 - Soc Nuclear Med
298 Purpose: Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease (ILD)
with poor prognosis and lung cancer (LC) as a frequent complication. Established Imaging …
with poor prognosis and lung cancer (LC) as a frequent complication. Established Imaging …
[68Ga] FAPI P ET/CT for imaging and treatment monitoring in a preclinical model of pulmonary fibrosis: comparison to [18F] FDG PET/CT
2449 Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease
with poor prognosis. Due to the lack of specific biomarkers for disease evaluation and …
with poor prognosis. Due to the lack of specific biomarkers for disease evaluation and …
Targeting Activated Fibroblasts for non-invasive detection of Lung Fibrosis
10 Objectives: Interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF), are
characterized by progressive lung fibrosis and cause significant morbidity and mortality in …
characterized by progressive lung fibrosis and cause significant morbidity and mortality in …
[HTML][HTML] Novel tracers for molecular imaging of interstitial lung disease: A state of the art review
B Broens, JW Duitman, GJC Zwezerijnen… - Autoimmunity …, 2022 - Elsevier
Interstitial lung disease is an overarching term for a wide range of disorders characterized by
inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include …
inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include …
[18F] FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the …
The use of [18F] FDG PET/CT as a biomarker in diffuse lung diseases is increasingly
recognized. We investigated the correlation between [18F] FDG uptake with histologic …
recognized. We investigated the correlation between [18F] FDG uptake with histologic …
[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity
ZT Rosenkrans, CF Massey, K Bernau… - European journal of …, 2022 - Springer
Purpose The lack of effective molecular biomarkers to monitor idiopathic pulmonary fibrosis
(IPF) activity or treatment response remains an unmet clinical need. Herein, we determined …
(IPF) activity or treatment response remains an unmet clinical need. Herein, we determined …
Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression
S Isser, A Maurer, G Reischl, M Schaller… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Invariably fatal and with a particularly fast progression, pulmonary fibrosis (PF) is currently
devoid of curative treatment options. Routine clinical diagnosis relies on breathing tests and …
devoid of curative treatment options. Routine clinical diagnosis relies on breathing tests and …